PureTech Health plc (LON:PRTC)
118.60
-1.60 (-1.33%)
Jul 6, 2026, 4:20 PM GMT
PureTech Health Employees
PureTech Health had 90 employees as of December 31, 2025. The number of employees increased by 34 or 60.71% compared to the previous year.
Employees
90
Change (1Y)
34
Growth (1Y)
60.71%
Revenue / Employee
38.46K GBP
Profits / Employee
-905.96K GBP
Market Cap
292.59M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 90 | 34 | 60.71% |
| Dec 31, 2024 | 56 | -34 | -37.78% |
| Dec 31, 2023 | 90 | -21 | -18.92% |
| Dec 31, 2022 | 111 | 16 | 16.84% |
| Dec 31, 2021 | 95 | -155 | -62.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Genus | 3,190 |
| Oxford Nanopore Technologies | 1,316 |
| Oxford Biomedica | 977 |
| hVIVO | 376 |
| 4basebio | 140 |
| Avacta Group | 81 |
| Scancell Holdings | 60 |
| Faron Pharmaceuticals Oy | 33 |
PureTech Health News
- 4 days ago - PureTech entity Celea raises $180 million to move lung disease drug into late stage trial - Reuters
- 4 days ago - PureTech Founded Entity Celea Therapeutics Completes $180 Million Financing to Advance Deupirfenidone as a Potential New Standard of Care to Treat Idiopathic Pulmonary Fibrosis (IPF) - Business Wire
- 25 days ago - PureTech Health: Results of Annual General Meeting - Business Wire
- 2 months ago - PureTech Health Earnings Call Transcript: H2 2025 - Transcripts
- 2 months ago - PureTech Health Annual report: H2 2025 - Filings
- 2 months ago - PureTech Health Annual report: H2 2025 - Filings
- 2 months ago - PureTech Health Annual report: H2 2025 - Filings
- 2 months ago - PureTech Health to delist American depositary shares from Nasdaq - TheFly